Skip to main content
NCBI home page
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1994 Aug;75(4):233–241.

Osteogenesis imperfecta: from phenotype to genotype and back again.

R Smith 1
PMCID: PMC2002243  PMID: 7947227

Abstract

The presumption that identification of the collagen gene mutations in OI would completely explain the phenotype is unjustified. Full understanding of this fragile bone syndrome will depend on the intelligent interpretation of both the biochemical abnormalities and the clinical features. Between these extremes there is a whole unexplored area of cell biology. To make further progress it seems that we shall have to pay as much attention to the phenotype as to the genotype.

Full text

PDF
233

Images in this article

236Figure 1
on p.236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andujar M. B., Couble P., Couble M. L., Magloire H. Differential expression of type I and type III collagen genes during tooth development. Development. 1991 Mar;111(3):691–698. doi: 10.1242/dev.111.3.691. [DOI] [PubMed] [Google Scholar]
  2. Barker D. D., Wu H., Hartung S., Breindl M., Jaenisch R. Retrovirus-induced insertional mutagenesis: mechanism of collagen mutation in Mov13 mice. Mol Cell Biol. 1991 Oct;11(10):5154–5163. doi: 10.1128/mcb.11.10.5154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bauze R. J., Smith R., Francis M. J. A new look at osteogenesis imperfecta. A clinical, radiological and biochemical study of forty-two patients. J Bone Joint Surg Br. 1975 Feb;57(1):2–12. [PubMed] [Google Scholar]
  4. Bonadio J., Saunders T. L., Tsai E., Goldstein S. A., Morris-Wiman J., Brinkley L., Dolan D. F., Altschuler R. A., Hawkins J. E., Jr, Bateman J. F. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7145–7149. doi: 10.1073/pnas.87.18.7145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Byers P. H. Brittle bones--fragile molecules: disorders of collagen gene structure and expression. Trends Genet. 1990 Sep;6(9):293–300. doi: 10.1016/0168-9525(90)90235-x. [DOI] [PubMed] [Google Scholar]
  6. Bächinger H. P., Morris N. P., Davis J. M. Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am J Med Genet. 1993 Jan 15;45(2):152–162. doi: 10.1002/ajmg.1320450204. [DOI] [PubMed] [Google Scholar]
  7. Cassella J. P., Ali S. Y. Abnormal collagen and mineral formation in osteogenesis imperfecta. Bone Miner. 1992 May;17(2):123–128. doi: 10.1016/0169-6009(92)90722-p. [DOI] [PubMed] [Google Scholar]
  8. Chipman S. D., Shapiro J. R., McKinstry M. B., Stover M. L., Branson P., Rowe D. W. Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV. J Bone Miner Res. 1992 Jul;7(7):793–805. doi: 10.1002/jbmr.5650070709. [DOI] [PubMed] [Google Scholar]
  9. Chipman S. D., Sweet H. O., McBride D. J., Jr, Davisson M. T., Marks S. C., Jr, Shuldiner A. R., Wenstrup R. J., Rowe D. W., Shapiro J. R. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1701–1705. doi: 10.1073/pnas.90.5.1701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cohn D. H., Starman B. J., Blumberg B., Byers P. H. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). Am J Hum Genet. 1990 Mar;46(3):591–601. [PMC free article] [PubMed] [Google Scholar]
  11. Constantinou-Deltas C. D., Ladda R. L., Prockop D. J. Somatic cell mosaicism: another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfecta. Am J Med Genet. 1993 Jan 15;45(2):246–251. doi: 10.1002/ajmg.1320450218. [DOI] [PubMed] [Google Scholar]
  12. Fedarko N. S., Moerike M., Brenner R., Robey P. G., Vetter U. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res. 1992 Aug;7(8):921–930. doi: 10.1002/jbmr.5650070809. [DOI] [PubMed] [Google Scholar]
  13. Gage J. P., Francis M. J., Whitaker G. E., Smith R. Dentine is biochemically abnormal in osteogenesis imperfecta. Clin Sci (Lond) 1986 Apr;70(4):339–346. doi: 10.1042/cs0700339. [DOI] [PubMed] [Google Scholar]
  14. Hall J. G. Review and hypotheses: somatic mosaicism: observations related to clinical genetics. Am J Hum Genet. 1988 Oct;43(4):355–363. [PMC free article] [PubMed] [Google Scholar]
  15. Khillan J. S., Olsen A. S., Kontusaari S., Sokolov B., Prockop D. J. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J Biol Chem. 1991 Dec 5;266(34):23373–23379. [PubMed] [Google Scholar]
  16. Kratochwil K., von der Mark K., Kollar E. J., Jaenisch R., Mooslehner K., Schwarz M., Haase K., Gmachl I., Harbers K. Retrovirus-induced insertional mutation in Mov13 mice affects collagen I expression in a tissue-specific manner. Cell. 1989 Jun 2;57(5):807–816. doi: 10.1016/0092-8674(89)90795-2. [DOI] [PubMed] [Google Scholar]
  17. Lightfoot S. J., Holmes D. F., Brass A., Grant M. E., Byers P. H., Kadler K. E. Type I procollagens containing substitutions of aspartate, arginine, and cysteine for glycine in the pro alpha 1 (I) chain are cleaved slowly by N-proteinase, but only the cysteine substitution introduces a kink in the molecule. J Biol Chem. 1992 Dec 15;267(35):25521–25528. [PubMed] [Google Scholar]
  18. Mörike M., Brenner R. E., Bushart G. B., Teller W. M., Vetter U. Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients. Biochem J. 1992 Aug 15;286(Pt 1):73–77. doi: 10.1042/bj2860073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Niyibizi C., Bonadio J., Byers P. H., Eyre D. R. Incorporation of type I collagen molecules that contain a mutant alpha 2(I) chain (Gly580-->Asp) into bone matrix in a lethal case of osteogenesis imperfecta. J Biol Chem. 1992 Nov 15;267(32):23108–23112. [PubMed] [Google Scholar]
  20. Prockop D. J., Constantinou C. D., Dombrowski K. E., Hojima Y., Kadler K. E., Kuivaniemi H., Tromp G., Vogel B. E. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue. Am J Med Genet. 1989 Sep;34(1):60–67. doi: 10.1002/ajmg.1320340112. [DOI] [PubMed] [Google Scholar]
  21. Prockop D. J., Kivirikko K. I. Heritable diseases of collagen. N Engl J Med. 1984 Aug 9;311(6):376–386. doi: 10.1056/NEJM198408093110606. [DOI] [PubMed] [Google Scholar]
  22. Sillence D. O., Senn A., Danks D. M. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979 Apr;16(2):101–116. doi: 10.1136/jmg.16.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Silver D., Miller J., Harrison R., Prockop D. J. Helical model of nucleation and propagation to account for the growth of type I collagen fibrils from symmetrical pointed tips: a special example of self-assembly of rod-like monomers. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9860–9864. doi: 10.1073/pnas.89.20.9860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Smith R. The molecular genetics of collagen disorders. Clin Sci (Lond) 1986 Aug;71(2):129–135. doi: 10.1042/cs0710129. [DOI] [PubMed] [Google Scholar]
  25. Stacey A., Bateman J., Choi T., Mascara T., Cole W., Jaenisch R. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene. Nature. 1988 Mar 10;332(6160):131–136. doi: 10.1038/332131a0. [DOI] [PubMed] [Google Scholar]
  26. Sykes B. Human genetics. Bone disease cracks genetics. Nature. 1990 Nov 1;348(6296):18–20. doi: 10.1038/348018a0. [DOI] [PubMed] [Google Scholar]
  27. Sykes B., Ogilvie D., Wordsworth P., Wallis G., Mathew C., Beighton P., Nicholls A., Pope F. M., Thompson E., Tsipouras P. Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet. 1990 Feb;46(2):293–307. [PMC free article] [PubMed] [Google Scholar]
  28. Sykes B. The molecular genetics of collagen. Bioessays. 1985 Sep;3(3):112–117. doi: 10.1002/bies.950030306. [DOI] [PubMed] [Google Scholar]
  29. Torre-Blanco A., Adachi E., Romanic A. M., Prockop D. J. Copolymerization of normal type I collagen with three mutated type I collagens containing substitutions of cysteine at different glycine positions in the alpha 1 (I) chain. J Biol Chem. 1992 Mar 5;267(7):4968–4973. [PubMed] [Google Scholar]
  30. Tsuneyoshi T., Westerhausen A., Constantinou C. D., Prockop D. J. Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix. J Biol Chem. 1991 Aug 25;266(24):15608–15613. [PubMed] [Google Scholar]
  31. Vetter U., Eanes E. D., Kopp J. B., Termine J. D., Robey P. G. Changes in apatite crystal size in bones of patients with osteogenesis imperfecta. Calcif Tissue Int. 1991 Oct;49(4):248–250. doi: 10.1007/BF02556213. [DOI] [PubMed] [Google Scholar]
  32. Vetter U., Fisher L. W., Mintz K. P., Kopp J. B., Tuross N., Termine J. D., Robey P. G. Osteogenesis imperfecta: changes in noncollagenous proteins in bone. J Bone Miner Res. 1991 May;6(5):501–505. doi: 10.1002/jbmr.5650060512. [DOI] [PubMed] [Google Scholar]
  33. Vetter U., Weis M. A., Mörike M., Eanes E. D., Eyre D. R. Collagen crosslinks and mineral crystallinity in bone of patients with osteogenesis imperfecta. J Bone Miner Res. 1993 Feb;8(2):133–137. doi: 10.1002/jbmr.5650080203. [DOI] [PubMed] [Google Scholar]
  34. Vogel B. E., Doelz R., Kadler K. E., Hojima Y., Engel J., Prockop D. J. A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away. J Biol Chem. 1988 Dec 15;263(35):19249–19255. [PubMed] [Google Scholar]
  35. Wallis G. A., Starman B. J., Zinn A. B., Byers P. H. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent. Am J Hum Genet. 1990 Jun;46(6):1034–1040. [PMC free article] [PubMed] [Google Scholar]
  36. Wallis G. A., Sykes B., Byers P. H., Mathew C. G., Viljoen D., Beighton P. Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible. J Med Genet. 1993 Jun;30(6):492–496. doi: 10.1136/jmg.30.6.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Watson R. B., Wallis G. A., Holmes D. F., Viljoen D., Byers P. H., Kadler K. E. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section. J Biol Chem. 1992 May 5;267(13):9093–9100. [PubMed] [Google Scholar]
  38. Willing M. C., Pruchno C. J., Atkinson M., Byers P. H. Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet. 1992 Sep;51(3):508–515. [PMC free article] [PubMed] [Google Scholar]
  39. Willing M. C., Pruchno C. J., Byers P. H. Molecular heterogeneity in osteogenesis imperfecta type I. Am J Med Genet. 1993 Jan 15;45(2):223–227. doi: 10.1002/ajmg.1320450214. [DOI] [PubMed] [Google Scholar]
  40. van der Rest M., Garrone R. Collagen family of proteins. FASEB J. 1991 Oct;5(13):2814–2823. [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES